444 related articles for article (PubMed ID: 29019492)
21. Supramolecular nanomedicines through rational design of self-assembling prodrugs.
Wang H; Monroe M; Leslie F; Flexner C; Cui H
Trends Pharmacol Sci; 2022 Jun; 43(6):510-521. PubMed ID: 35459589
[TBL] [Abstract][Full Text] [Related]
22. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
23. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
[TBL] [Abstract][Full Text] [Related]
24. Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy.
Ding C; Chen C; Zeng X; Chen H; Zhao Y
ACS Nano; 2022 Sep; 16(9):13513-13553. PubMed ID: 36048467
[TBL] [Abstract][Full Text] [Related]
25. Synthetic routes to nanomaterials containing anthracyclines: noncovalent systems.
Piorecka K; Kurjata J; Stanczyk M; Stanczyk WA
Biomater Sci; 2018 Sep; 6(10):2552-2565. PubMed ID: 30140825
[TBL] [Abstract][Full Text] [Related]
26. Ester Prodrugs of Ketoprofen: Synthesis, In Vitro Stability, In Vivo Biological Evaluation and In Silico Comparative Docking Studies Against COX-1 and COX-2.
Ahmed M; Azam F; Gbaj A; Zetrini AE; Abodlal AS; Rghigh A; Elmahdi E; Hamza A; Salama M; Bensaber SM
Curr Drug Discov Technol; 2016; 13(1):41-57. PubMed ID: 26785683
[TBL] [Abstract][Full Text] [Related]
27. Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles.
Deng Z; Liu S
J Control Release; 2020 Oct; 326():276-296. PubMed ID: 32682899
[TBL] [Abstract][Full Text] [Related]
28. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
29. Light-triggered, self-immolative nucleic Acid-drug nanostructures.
Tan X; Li BB; Lu X; Jia F; Santori C; Menon P; Li H; Zhang B; Zhao JJ; Zhang K
J Am Chem Soc; 2015 May; 137(19):6112-5. PubMed ID: 25924099
[TBL] [Abstract][Full Text] [Related]
30. Prodrug Strategies in the CNS Drugs: Small Modification Makes Big Improvements.
Kang T; Miao Z; Liu S; Ke B
Curr Top Med Chem; 2021; 21(24):2157-2169. PubMed ID: 34315372
[TBL] [Abstract][Full Text] [Related]
31. Prodrug strategies for antihypertensives.
Dhaneshwar SS; Sharma M; Patel V; Desai U; Bhojak J
Curr Top Med Chem; 2011; 11(18):2299-317. PubMed ID: 21671866
[TBL] [Abstract][Full Text] [Related]
32. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
33. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).
Springer CJ; Dowell R; Burke PJ; Hadley E; Davis DH; Blakey DC; Melton RG; Niculescu-Duvaz I
J Med Chem; 1995 Dec; 38(26):5051-65. PubMed ID: 8544182
[TBL] [Abstract][Full Text] [Related]
34. Biomimetic nanoassemblies of 1-O-octodecyl-2-conjugated linoleoyl-sn-glycero-3-phosphatidyl gemcitabine with phospholipase A
Zuo J; Tong L; Du L; Yang M; Jin Y
Colloids Surf B Biointerfaces; 2017 Apr; 152():467-474. PubMed ID: 28187380
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of carbamate prodrugs of SQ109 as antituberculosis agents.
Meng Q; Luo H; Liu Y; Li W; Zhang W; Yao Q
Bioorg Med Chem Lett; 2009 May; 19(10):2808-10. PubMed ID: 19362471
[TBL] [Abstract][Full Text] [Related]
36. Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.
He HT; Xu CR; Song X; Siahaan TJ
J Pept Res; 2003 Jun; 61(6):331-42. PubMed ID: 12753380
[TBL] [Abstract][Full Text] [Related]
37. Amino Acids in the Development of Prodrugs.
Vale N; Ferreira A; Matos J; Fresco P; Gouveia MJ
Molecules; 2018 Sep; 23(9):. PubMed ID: 30208629
[TBL] [Abstract][Full Text] [Related]
38. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
39. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
40. Anticancer prodrugs: an overview of major strategies and recent developments.
Arpicco S; Dosio F; Stella B; Cattel L
Curr Top Med Chem; 2011; 11(18):2346-81. PubMed ID: 21671864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
